Brown Advisory’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,231,198
| Closed | -$31.3M | – | 1456 |
|
|
2026
Q1 | $31.3M | Buy |
2,231,198
+295,396
| +15% | +$3.98M | 0.05% | 253 |
|
|
2025
Q4 | $21.7M | Sell |
1,935,802
-290,954
| -13% | -$3.33M | 0.03% | 316 |
|
|
2025
Q3 | $25.7M | Buy |
2,226,756
+417,921
| +23% | +$4.89M | 0.03% | 288 |
|
|
2025
Q2 | $22.1M | Sell |
1,808,835
-122,328
| -6% | -$1.54M | 0.03% | 301 |
|
|
2025
Q1 | $27.7M | Buy |
1,931,163
+26,069
| +1% | +$407K | 0.04% | 261 |
|
|
2024
Q4 | $30.3M | Buy |
1,905,094
+204,218
| +12% | +$4.04M | 0.04% | 281 |
|
|
2024
Q3 | $40.9M | Buy |
1,700,876
+30,093
| +2% | +$688K | 0.05% | 247 |
|
|
2024
Q2 | $33.3M | Buy |
1,670,783
+274,920
| +20% | +$5.35M | 0.04% | 259 |
|
|
2024
Q1 | $27.8M | Buy |
+1,395,863
| New | +$27M | 0.04% | 291 |
|
|
2021
Q2 | – | Sell |
-5,148
| Closed | -$225K | – | 1077 |
|
|
2021
Q1 | $225K | Hold |
5,148
| – | – | ﹤0.01% | 1004 |
|
|
2020
Q4 | $236K | Buy |
+5,148
| New | +$214K | ﹤0.01% | 930 |
|
|
2019
Q4 | – | Sell |
-6,245
| Closed | -$234K | – | 1042 |
|
|
2019
Q3 | $234K | Sell |
6,245
-237
| -4% | -$9.04K | ﹤0.01% | 911 |
|
|
2019
Q2 | $283K | Sell |
6,482
-106
| -2% | -$4.53K | ﹤0.01% | 883 |
|
|
2019
Q1 | $282K | Sell |
6,588
-273
| -4% | -$12.2K | ﹤0.01% | 1138 |
|
|
2018
Q4 | $308K | Buy |
6,861
+22
| +0.3% | +$1.15K | ﹤0.01% | 1065 |
|
|
2018
Q3 | $469K | Sell |
6,839
-100
| -1% | -$6.44K | ﹤0.01% | 1009 |
|
|
2018
Q2 | $397K | Buy |
6,939
+131
| +2% | +$6.92K | ﹤0.01% | 1032 |
|
|
2018
Q1 | $314K | Buy |
6,808
+69
| +1% | +$3.28K | ﹤0.01% | 958 |
|
|
2017
Q4 | $311K | Sell |
6,739
-1,049
| -13% | -$48.2K | ﹤0.01% | 1033 |
|
|
2017
Q3 | $351K | Sell |
7,788
-276
| -3% | -$11.8K | ﹤0.01% | 963 |
|
|
2017
Q2 | $318K | Buy |
8,064
+375
| +5% | +$14.2K | ﹤0.01% | 999 |
|
|
2017
Q1 | $293K | Sell |
7,689
-27
| -0.3% | -$1.05K | ﹤0.01% | 987 |
|
|
2016
Q4 | $286K | Sell |
7,716
-246
| -3% | -$8.79K | ﹤0.01% | 943 |
|
|
2016
Q3 | $275K | Buy |
7,962
+64
| +0.8% | +$2.24K | ﹤0.01% | 903 |
|
|
2016
Q2 | $256K | Sell |
7,898
-70
| -0.9% | -$2.14K | ﹤0.01% | 898 |
|
|
2016
Q1 | $229K | Buy |
+7,968
| New | +$212K | ﹤0.01% | 890 |
|
Other funds holding AVNS
Brown Advisory's AVNS Position: Q2 2026 in Review
Brown Advisory sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 2,231,198 shares — an estimated $31.3M sold.
Brown Advisory first reported a position in AVNS in Q1 2016 and held it in 26 quarters. The position peaked at $40.9M in Q3 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.
- Brown Advisory reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
- Brown Advisory sold 2,231,198 Avanos Medical shares in Q2 2026, an estimated $31.3M.
- Brown Advisory first reported a position in Avanos Medical in Q1 2016 and held it in 26 quarters.
- Brown Advisory's Avanos Medical position peaked at $40.9M in Q3 2024.
- 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.